OC 17 - Novel Developments in Diagnostics

Moderator(s)

• 

  Steve Kitchen, PhD

  Lead Scientist
  Department of Coagulation
  Sheffield Haemophilia and Thrombosis Centre
  sheffield, England, United Kingdom
• MS

  Matthew Sims, BA, BM BCh, MRCP, FRCPath

  Clinical Research Training Fellow
  Haematology
  University of Cambridge

Presentations:

• 10:45 AM – 11:00 AM

  Growth differentiation factor-15 is related to adverse prognosis in patients with polyvascular disease receiving dual antithrombotic therapy
  

  Presenting Author: Elena Krivosheeva, PhD – NATIONAL MEDICAL RESEARCH CENTER OF CARDIOLOGY Ministry of Health of the Russian Federation

  Co-Author: Andrey Komarov – NATIONAL MEDICAL RESEARCH CENTER OF CARDIOLOGY Ministry of Health of the Russian Federation, DEPARTMENT OF CLINICAL PROBLEMS OF ATHEROTHROMBOSIS

  Co-Author: Anatoly Dobrovolsky – NATIONAL MEDICAL RESEARCH CENTER OF CARDIOLOGY Ministry of Health of the Russian Federation, DEPARTMENT OF CLINICAL PROBLEMS OF ATHEROTHROMBOSIS

  Co-Author: Elena Titaeva – NATIONAL MEDICAL RESEARCH CENTER OF CARDIOLOGY Ministry of Health of the Russian Federation, DEPARTMENT OF CLINICAL PROBLEMS OF ATHEROTHROMBOSIS

  Co-Author: Olga Pogorelova – NATIONAL MEDICAL RESEARCH CENTER OF CARDIOLOGY Ministry of Health of the Russian Federation, ULTRASOUND DIVISION

  Co-Author: Tatiana Balakhonova – NATIONAL MEDICAL RESEARCH CENTER OF CARDIOLOGY Ministry of Health of the Russian Federation, ULTRASOUND DIVISION

  Co-Author: Elizaveta Panchenko – NATIONAL MEDICAL RESEARCH CENTER OF CARDIOLOGY Ministry of Health of the Russian Federation, DEPARTMENT OF CLINICAL PROBLEMS OF ATHEROTHROMBOSIS
• 11:00 AM – 11:15 AM

  The measurement of a next-generation FVIII Mimetic, Mim8, using tissue factor triggered calibrated automated thrombography
  

  Presenting Author: Annette E. Bowyer, N/A, PhD – Department of Coagulation

  Co-Author: Steve Kitchen, PhD – Sheffield Haemophilia and Thrombosis Centre

  Co-Author: Mirella Ezban – NovoNordisk A/S
• 11:15 AM – 11:30 AM

  A collaborative study to harmonize thrombin generation assays for measurement of procoagulant activity in immune globulins
  

  Presenting Author: Maria Shea – US Food & Drug Administration

  Co-Author: Leonid Parunov – US Food and Drug Administration

  Co-Author: Stella Williams – National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency

  Co-Author: John Hogwood – National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency

  Co-Author: Stepan S. Surov – US Food & Drug Administration

  Co-Author: Yideng Liang – US Food & Drug Administration

  Co-Author: Elaine Gray – National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency

  Co-Author: Mikhail V. Ovanesov – US Food & Drug Administration
• 11:30 AM – 11:45 AM

  Effects of andexanet alfa on different thrombin generation and anti-Xa-methods in vitro.
  

  Presenting Author: Yvonne Henskens, MSc PhD – Central Diagnostic Laboratory Maastricht University Medical Centre +, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands.

  Co-Author: Anouk Gulpen – Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands

  Co-Author: Maaike Bruurs – Central Diagnostic Laboratory, Maastricht University Medical Centre +

  Co-Author: Rene van Oerle – Central Diagnostic Laboratory, MUMC+ and Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands;

  Co-Author: Kristien Winckers – Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University

  Co-Author: Renske Olie – Departments of Biochemistry nd vascular medicine, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands;

  Co-Author: Arina J. ten Cate-Hoek – Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands; Thrombosis Expertise Center, Heart+ Vascular Center, Maastricht University Medical Center, Maastricht, the Netherlands

  Co-Author: Henri M.H. Spronk – Departments of Biochemistry and Internal Medicine, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands; Thrombosis Expertise Center, Heart+ Vascular Center, Maastricht University Medical Center, Maastricht, the Netherlands

  Co-Author: Hugo ten Cate – Departments of Biochemistry and Internal Medicine, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands;
• 11:45 AM – 12:00 PM

  Direct Oral Anti-Coagulant (DOAC) external quality assessment (EQA) scheme assay results and interpretations from UKNEQAS BC DOAC Survey 19 2021.
  

  Presenting Author: Christopher Mark Peter Reilly-Stitt, MSc – UK NEQAS BC

  Co-Author: Anna Lowe – UK NEQAS Blood Coagulation

  Co-Author: Ian Jennings – UK NEQAS BC

  Co-Author: Steve Kitchen, PhD – Sheffield Haemophilia and Thrombosis Centre

  Co-Author: Dianne P. Kitchen – UK NEQAS BC

  Co-Author: Isobel Walker – UK NEQAS BC